Urine proteomic insights from the belimumab in lupus nephritis trial

OBJECTIVE: Urine proteomic approaches have shown promise in identifying biological pathways in lupus nephritis (LN) which are not captured on renal histopathology or by measurement of proteinuria alone. We investigated how the urine proteome changes with treatment response and with belimumab therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Weeding, Emma, Fava, Andrea, Mohan, Chandra, Magder, Laurence, Goldman, Daniel, Petri, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516299/
https://www.ncbi.nlm.nih.gov/pubmed/36167482
http://dx.doi.org/10.1136/lupus-2022-000763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516299/
https://www.ncbi.nlm.nih.gov/pubmed/36167482
http://dx.doi.org/10.1136/lupus-2022-000763

Ejemplares similares